Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells.

Samuelson EM, Laird RM, Maue AC, Rochford R, Hayes SM.

Immunol Cell Biol. 2012 Jul;90(6):620-9. doi: 10.1038/icb.2011.76. Epub 2011 Sep 6.

2.

Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing γδ T cells.

Laird RM, Laky K, Hayes SM.

J Immunol. 2010 Dec 1;185(11):6518-27. doi: 10.4049/jimmunol.1002766. Epub 2010 Oct 25.

3.

The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.

Texido G, Su IH, Mecklenbräuker I, Saijo K, Malek SN, Desiderio S, Rajewsky K, Tarakhovsky A.

Mol Cell Biol. 2000 Feb;20(4):1227-33.

5.

Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.

Case JB, Bonami RH, Nyhoff LE, Steinberg HE, Sullivan AM, Kendall PL.

J Immunol. 2015 Jul 1;195(1):61-70. doi: 10.4049/jimmunol.1400803. Epub 2015 Jun 1.

6.

The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells.

Amano H, Amano E, Moll T, Marinkovic D, Ibnou-Zekri N, Martinez-Soría E, Semac I, Wirth T, Nitschke L, Izui S.

J Immunol. 2003 Mar 1;170(5):2293-301.

7.
8.

Generation of protective T cell-independent antiviral antibody responses in SCID mice reconstituted with follicular or marginal zone B cells.

Guay HM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E.

J Immunol. 2009 Jul 1;183(1):518-23. doi: 10.4049/jimmunol.0900068.

9.

Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.

Malek SN, Dordai DI, Reim J, Dintzis H, Desiderio S.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7351-6.

10.

Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.

Compeer EB, Janssen W, van Royen-Kerkhof A, van Gijn M, van Montfrans JM, Boes M.

Oncotarget. 2015 May 10;6(13):10759-71.

11.

Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.

Whyburn LR, Halcomb KE, Contreras CM, Lowell CA, Witte ON, Satterthwaite AB.

J Immunol. 2003 Aug 15;171(4):1850-8.

12.

Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.

Stolp J, Mariño E, Batten M, Sierro F, Cox SL, Grey ST, Silveira PA.

J Immunol. 2013 Jul 1;191(1):97-109. doi: 10.4049/jimmunol.1203252. Epub 2013 Jun 5.

13.

Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.

Venkataraman C, Muthusamy N, Muthukkumar S, Bondada S.

J Immunol. 1998 Apr 1;160(7):3322-9.

14.

Mechanisms governing B cell developmental defects in invariant chain-deficient mice.

Benlagha K, Park SH, Guinamard R, Forestier C, Karlsson L, Chang CH, Bendelac A.

J Immunol. 2004 Feb 15;172(4):2076-83.

15.

Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice.

Scheikl T, Reis B, Pfeffer K, Holzmann B, Beer S.

Mol Immunol. 2009 Feb;46(5):969-77. doi: 10.1016/j.molimm.2008.09.023. Epub 2008 Oct 31.

PMID:
18950867
16.

The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.

Xu Y, Beavitt SJ, Harder KW, Hibbs ML, Tarlinton DM.

J Immunol. 2002 Dec 15;169(12):6910-8.

17.

B cell developmental requirement for the G alpha i2 gene.

Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J.

J Immunol. 2003 Feb 15;170(4):1707-15. Erratum in: J Immunol. 2004 Jul 1;173(1):695.

18.

IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Feng J, Wang H, Shin DM, Masiuk M, Qi CF, Morse HC 3rd.

J Immunol. 2011 Feb 1;186(3):1458-66. doi: 10.4049/jimmunol.1001950. Epub 2010 Dec 22.

19.

Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.

Wang JH, Li J, Wu Q, Yang P, Pawar RD, Xie S, Timares L, Raman C, Chaplin DD, Lu L, Mountz JD, Hsu HC.

J Immunol. 2010 Jan 1;184(1):442-51. doi: 10.4049/jimmunol.0900870. Epub 2009 Nov 30.

20.

The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.

Zhang X, Paun A, Claudio E, Wang H, Siebenlist U.

J Immunol. 2013 Dec 15;191(12):5984-92. doi: 10.4049/jimmunol.1300611. Epub 2013 Nov 15.

Items per page

Supplemental Content

Write to the Help Desk